Researcher Profile Statistics: moustafa, Elham
Geo Map
Region
#
EU - Europe
7
AS - Asia, other
5
AF - Africa
2
NA - North America
2
Unknown
34
Total
50
Country
#
FI - Finland
5
CN - China
4
DE - Germany
2
EG - Egypt
2
US - United States of America
2
MY - Malaysia
1
Unknown
34
Total
50
City
#
Hefei
2
Jacksonville
2
Unknown
46
Total
50
Most viewed items
#
ID: 157379 - ASSOCIATION OF COMPLEMENT C3 AND INTERLEUKIN-1 WITH FOOT INFECTIONS IN DIABETIC PATIENTS
27
Total
27
Most type viewed
#
ID: all -
50
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
50
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
2 2 0 0
1 0
5
2020
4 2
2 0 0 0
0 0 0 0
0 0
8
2021
0 0
0 0 0 0
0 0 0 0
0 2
2
2022
0 0
0 0 2 0
0 0 0 0
0 0
2
2023
0 2
3 2 1 1
0 0 2 1
1 0
13
2024
3 1
4 0 0 1
0 0 0 0
0 0
9
Ever
50
Geo Map
Region | # |
---|---|
EU - Europe | 7 |
AS - Asia, other | 5 |
AF - Africa | 2 |
NA - North America | 2 |
Unknown | 34 |
Total | 50 |
Country | # |
---|---|
FI - Finland | 5 |
CN - China | 4 |
DE - Germany | 2 |
EG - Egypt | 2 |
US - United States of America | 2 |
MY - Malaysia | 1 |
Unknown | 34 |
Total | 50 |
City | # |
---|---|
Hefei | 2 |
Jacksonville | 2 |
Unknown | 46 |
Total | 50 |
Most viewed items | # |
---|---|
ID: 157379 - ASSOCIATION OF COMPLEMENT C3 AND INTERLEUKIN-1 WITH FOOT INFECTIONS IN DIABETIC PATIENTS | 27 |
Total | 27 |
Most type viewed | # |
---|---|
ID: all - | 50 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 50 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 1 | 0 | 5 |
2020 | 4 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
2022 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
2023 | 0 | 2 | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 0 | 13 |
2024 | 3 | 1 | 4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
Ever | 50 |